Search details
1.
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial.
Contemp Oncol (Pozn)
; 27(4): 217-223, 2023.
Article
in English
| MEDLINE | ID: mdl-38405208
2.
Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial.
Nat Med
; 2024 Jun 19.
Article
in English
| MEDLINE | ID: mdl-38898120
3.
Increasing reliability of APACHE II scores in a medical-surgical intensive care unit: a quality improvement study.
Am J Crit Care
; 18(1): 58-64, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-19116406
Results
1 -
3
de 3
1
Next >
>>